IBDEI3FF ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,57643,2)
 ;;=^5133679
 ;;^UTILITY(U,$J,358.3,57644,0)
 ;;=L97.912^^267^2887^12
 ;;^UTILITY(U,$J,358.3,57644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57644,1,3,0)
 ;;=3^Non-Prs Chr Ulc,Rt Low Leg w/ Fat Layer Exposed
 ;;^UTILITY(U,$J,358.3,57644,1,4,0)
 ;;=4^L97.912
 ;;^UTILITY(U,$J,358.3,57644,2)
 ;;=^5133681
 ;;^UTILITY(U,$J,358.3,57645,0)
 ;;=L97.913^^267^2887^13
 ;;^UTILITY(U,$J,358.3,57645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57645,1,3,0)
 ;;=3^Non-Prs Chr Ulc,Rt Low Leg w/ Necrosis of Muscle
 ;;^UTILITY(U,$J,358.3,57645,1,4,0)
 ;;=4^L97.913
 ;;^UTILITY(U,$J,358.3,57645,2)
 ;;=^5133683
 ;;^UTILITY(U,$J,358.3,57646,0)
 ;;=L97.914^^267^2887^14
 ;;^UTILITY(U,$J,358.3,57646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57646,1,3,0)
 ;;=3^Non-Prs Chr Ulc,Rt Low Leg w/ Necrosis of Bone
 ;;^UTILITY(U,$J,358.3,57646,1,4,0)
 ;;=4^L97.914
 ;;^UTILITY(U,$J,358.3,57646,2)
 ;;=^5133685
 ;;^UTILITY(U,$J,358.3,57647,0)
 ;;=L97.919^^267^2887^15
 ;;^UTILITY(U,$J,358.3,57647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57647,1,3,0)
 ;;=3^Non-Prs Chr Ulc,Rt Low Leg w/ Unspec Severity
 ;;^UTILITY(U,$J,358.3,57647,1,4,0)
 ;;=4^L97.919
 ;;^UTILITY(U,$J,358.3,57647,2)
 ;;=^5133688
 ;;^UTILITY(U,$J,358.3,57648,0)
 ;;=L97.922^^267^2887^7
 ;;^UTILITY(U,$J,358.3,57648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57648,1,3,0)
 ;;=3^Non-Prs Chr Ulc,Lt Low Leg w/ Fat Layer Exposed
 ;;^UTILITY(U,$J,358.3,57648,1,4,0)
 ;;=4^L97.922
 ;;^UTILITY(U,$J,358.3,57648,2)
 ;;=^5133682
 ;;^UTILITY(U,$J,358.3,57649,0)
 ;;=L97.921^^267^2887^11
 ;;^UTILITY(U,$J,358.3,57649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57649,1,3,0)
 ;;=3^Non-Prs Chr Ulc,Lt Low Leg,Limited to Brkdwn Skin
 ;;^UTILITY(U,$J,358.3,57649,1,4,0)
 ;;=4^L97.921
 ;;^UTILITY(U,$J,358.3,57649,2)
 ;;=^5133680
 ;;^UTILITY(U,$J,358.3,57650,0)
 ;;=L97.923^^267^2887^8
 ;;^UTILITY(U,$J,358.3,57650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57650,1,3,0)
 ;;=3^Non-Prs Chr Ulc,Lt Low Leg w/ Necrosis of Muscle
 ;;^UTILITY(U,$J,358.3,57650,1,4,0)
 ;;=4^L97.923
 ;;^UTILITY(U,$J,358.3,57650,2)
 ;;=^5133684
 ;;^UTILITY(U,$J,358.3,57651,0)
 ;;=L97.924^^267^2887^9
 ;;^UTILITY(U,$J,358.3,57651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57651,1,3,0)
 ;;=3^Non-Prs Chr Ulc,Lt Low Leg w/ Necrosis of Bone
 ;;^UTILITY(U,$J,358.3,57651,1,4,0)
 ;;=4^L97.924
 ;;^UTILITY(U,$J,358.3,57651,2)
 ;;=^5133686
 ;;^UTILITY(U,$J,358.3,57652,0)
 ;;=L97.929^^267^2887^10
 ;;^UTILITY(U,$J,358.3,57652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57652,1,3,0)
 ;;=3^Non-Prs Chr Ulc,Lt Low Leg w/ Unspec Severity
 ;;^UTILITY(U,$J,358.3,57652,1,4,0)
 ;;=4^L97.929
 ;;^UTILITY(U,$J,358.3,57652,2)
 ;;=^5133689
 ;;^UTILITY(U,$J,358.3,57653,0)
 ;;=R21.^^267^2887^21
 ;;^UTILITY(U,$J,358.3,57653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57653,1,3,0)
 ;;=3^Rash/Nonspecific Skin Eruption
 ;;^UTILITY(U,$J,358.3,57653,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,57653,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,57654,0)
 ;;=Z23.^^267^2888^1
 ;;^UTILITY(U,$J,358.3,57654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57654,1,3,0)
 ;;=3^Immunization Encounter
 ;;^UTILITY(U,$J,358.3,57654,1,4,0)
 ;;=4^Z23.
 ;;^UTILITY(U,$J,358.3,57654,2)
 ;;=^5062795
 ;;^UTILITY(U,$J,358.3,57655,0)
 ;;=Z48.00^^267^2889^1
 ;;^UTILITY(U,$J,358.3,57655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57655,1,3,0)
 ;;=3^Change/Removal Nonsurg Wound Dressing
 ;;^UTILITY(U,$J,358.3,57655,1,4,0)
 ;;=4^Z48.00
 ;;^UTILITY(U,$J,358.3,57655,2)
 ;;=^5063033
 ;;^UTILITY(U,$J,358.3,57656,0)
 ;;=Z48.01^^267^2889^2
 ;;^UTILITY(U,$J,358.3,57656,1,0)
 ;;=^358.31IA^4^2
